L Lin, L Corash and JC Osselaer. Protection Against TA-GVHD in Platelet Transfusion by Pathogen Inactivation with the INTERCEPT Blood System™ - Gamma Irradiation is NOT the Only Answer. Haematologica 2010;95(extra):86-93.
H Isola, D Brandner, E Stahl, L Corash and JP Cazenave. Monitoring photochemical pathogen inactivation treatment using amotosalen and ultraviolet-A light: evaluation of an indicator label.Vox Sang 2010 Nov;99(4):402 [Epub ahead of print] > View abstract
L Corash, J Sying Lin, C Sherman and J Eiden. Determination of Acute Lung Injury Following Repeated Platelet Transfusions.Blood 2010 Oct. 8 [Epub ahead of print] > View abstract
JP Cazenave, H Isola, C Waller, et al. Use of additive solutions and pathogen inactivation treatment of platelet components in a regional blood center: impact on patient outcomes and component utilization during a 3-year period. Transfusion. 2010 Sep. [Epub ahead of print] > View abstract
P Chavarin, F Cognasse, C Argaud, M Vidal, C De Putter, F Boussoulade, C Ripaud, S Acquart, L Lin, O Garraud. In vitro assessment of apheresis and pooled buffy coat platelet components suspended in plasma and SSP+ photochemically treated with amotosalen and UVA for pathogen inactivation (INTERCEPT Blood System). Vox Sang 2010 Aug 24. [Epub ahead of print] > View abstract
